SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that its board of directors has decided to make an equity investment in Novavax, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, securi
LOTTE BIOLOGICS announced that they have signed a Memorandum of Understanding (MOU) with Roche Diagnostics, the diagnostic division of the global healthcare leading company Roche Group, to cement their cooperation in the Contract Development and Manufacturing Organization (CDMO) sphere.This MOU, sig
The author is an analyst for NH Investment & Securities. He can be reached at esshim@nhqv.com -- Ed.H.PIO recorded quarterly-high earnings in 2Q23 on the back of an earnings turnaround at its main business and earnings growth at subsidiaries. Led by new brand launches and cash utiliztion, the compan
Samsung Bioepis is said to be reviewing the acquisition of the biosimilar business unit of U.S. biotech firm Biogen.According to the biotech industry on Aug. 2, Samsung Bioepis is considering acquiring Biogen’s biosimilar business unit, which has recently been put up for sale.Biogen has been a colla
The Korea Atomic Energy Research Institute (KAERI) has developed a technology that can mass produce radiopharmaceuticals.KAERI’s Proton Science Research Center announced on July 31 that it has developed an analytical method that can isolate copper-67, a radioactive substance used for treatment, in h
The trend of collaborations between domestic and foreign enterprises of various sizes to achieve success in new drug development is on the rise. Such collaborations are viewed within the industry as a potential model for “Korean-style Open Innovation” in the pharmaceutical and biotech sectors.Accord
Companies investing in biopharmaceutical-related technologies and production facilities will now be eligible for a maximum tax deduction of 35 percent.On July 27, the Ministry of Economy and Finance held the 56th session of the Tax System Advancement Review Committee presided over by Deputy Prime Mi
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, today released its 2023 Environmental, Social and Governance (ESG) Report.This is the company’s second ESG Report following last year to fulfill its commitment to engaging in sustain
After two decades since the establishment of diplomatic relations in 1992, China is likely to be knocked out from its role as the largest trading partner of the South Korean economy. The void left by China is quickly being filled by Korea’s ally, the United States.South Korea’s current account surpl
HK inno.N Corp. announced on July 24 that its new drug for gastroesophageal reflux disease, K-CAB (active ingredient: Tegoprazan), has been granted product approval by Peru's National Medicines Authority (DIGEMID) on July 21.In 2018, the company inked a contract with “Laboratorios Carnot,” a lea
Both domestic and global information technology (IT) giants are now joining pharmaceutical and biotech companies in utilizing artificial intelligence (AI) for drug development. Some AI drug development firms are currently in the process of going public through initial public offerings (IPOs).Accordi
The government has designated seven specialized complexes for the nation’s advanced strategic industries such as semiconductors, secondary batteries, and displays. In addition to this, five specialized complexes for materials, parts and equipment have also been newly designated to focus on five othe
The Korean government has announced its intention to become the world’s No. 1 biopharmaceutical powerhouse by 2030 by attracting 15.7 trillion won in private investment and providing related support under the Bioeconomy 2.0 Initiative.At the Bioeconomy 2.0 Roundtable held at the Seoul BioHub on July
Elliott Management, a U.S.-based private equity fund, criticized the South Korean government’s decision to file an appeal lawsuit against an international investment dispute decision, saying that “the rejection of the decision sends the wrong message that South Korea is tolerant of corruption.” The
SK Co., Ltd. announced on July 18 that it had selected Brain Asset Management as the preferred negotiating partner for capital raising (pre-IPO) of its contract development and manufacturing organization (CDMO) subsidiary SK pharmteco. The scale of the investment attraction is around 500 million dol
Korea has ranked third in Asia in the global biopharma resilience index rankings in 2023. This represented a drop of two notches from 2021 when the COVID-19 pandemic was rampant. In the global rankings of 22 countries, Korea dropped sharply from 7th place to 12th over the same period. The decline wa
Samsung Electronics has slipped to fourth place in global semiconductor market capitalization rankings, surpassed by U.S.-based fabless semiconductor firm Broadcom. Non-memory companies such as Nvidia and Broadcom are expanding their territories through massive investments and mergers and acquisitio
“Huawei is willing to share cutting-edge innovations in the form of patents with the world,” said the company’s Chief Legal Officer, Song Liuping, who added, “These will support the common, sustainable development of industries globally.”His remarks were made at Huawei’s annual flagship event on inn
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company’s CEO, Jaeyong Ahn has virtually participated as a panelist in the academic workshop session of ‘Pandemic Product Research and Development: Insights from P
GC Biopharma’s and SK plasma’s entries into Indonesia will accelerate this year. GC Biopharma is expected to finalize all procedures within this year after receiving approval for business rights related to the construction of a blood product factory and a technology transfer from the Indonesian gove